Do you know the address? ilosone 250 para que sirve The French drugmaker said it would withdraw its U.S.application for diabetes treatment lixisenatide to wait forresults from an ongoing cardiovascular patient study. Thedecision will delay the drug's launch in the world's biggestmarket.
